Levels of client satisfaction following the application of a person-centered management approach in persons suffering with Schizophrenia
Main Article Content
Abstract
Article Details
References
Christodoulou, G.N. (ed). (1987). Psychosomatic Medicine. New York: Plenum Press.
Patwardhan, B., Warude, D., Pushpangadan, P. & Bhatt, N. (2005). Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-based Complementary and Alternative Medicine 2, 465-473.
Cloninger, C.R. (2004). Feeling Good: The Science of Well-Being. New York: Oxford University Press.
Cox, J., Campbell, A. & Fulford, K.W.M. (2007). Medicine of the Person. London: Kingsley Publishers.
Mezzich, J.E. (2005). Positive health: Conceptual place, dimensions and implications. Psychopathology 38, 177-179.
Trivedi, J.K., Kallivayalil, R.A., Pongsupap, Y. & Jilani, A.Q. (2011). South Asian person-centered psychiatric health care projects: an exploratory overview. International Journal of Person Centered Medicine 1 (2) 468-474.
ICD-10, Classification of Mental and Behavioral Disorders-Diagnostic criteria for research (DCR), World Health organization, Geneva,1992.
Kay, S.R., Fiszbein, A. & Opler, LA. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (2) 261-276.
Endicott, J., Spitzer, R., Fleiss, J. & Cohen, J. (1976). The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33 (6) 766-771.
Attkinsson, C.C. & Greenfield, T.K. (1994). The client satisfaction questionnaires-8 and the service satisfaction questionnaires-30. The use of psychological testing in the treatment planning and outcome assessment. (Maruish, M.E., ed). Hillsdale, NJ: Erlbaum associates.
Ministry of Home affairs, Government of India. (2011). Census of India. http://censusindia.gov.in/.
Lieberman, J.A., Stroup, S.T., McEvoy, J.P., et al., 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209–1223.
Jones, P.B., Davies, L., Barnes, T.R., Davis, L., Dunn, G., Lloyd, H., Hayhurst, K.P., Murray, R.M., Marwick, A. & Lewis, S.W. (2006). Randomized controlled trial of effect on quality of life of second-generation versus first generation antipsychotic drugs in schizophrenia. Archives of General Psychiatry 63, 1079–1087.
McEvoy, J.P., Lieberman, J.A., Stroup, T.S., Davis, S.M., Meltzer, H.Y., Rosenheck, R.A., Swartz, M.S., Perkins, D.O., Keefe, R.S., Davis, C.E., Severe, J., Hsiao, J.K. & CATIE Investigators. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior antipsychotic treatment. American Journal of Psychiatry 163 (4) 600–610.
Davies, L.M., Lewis, S., Jones, P.B., Barnes, T.R., Gaughran, F., Hayhurst, K., Markwick, A., Lloyd, H. & CUTLASS team. (2007). Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomized controlled trial in schizophrenia responding poorly to previous therapy. British Journal of Psychiatry 191, 14–22.